Published in Cephalalgia on June 01, 1996
Molecular genetics of migraine. Hum Genet (2009) 1.91
Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nat Genet (2012) 1.64
A susceptibility locus for migraine with aura, on chromosome 4q24. Am J Hum Genet (2002) 1.55
Interictal cortical hyperresponsiveness in migraine is directly related to the presence of aura. Cephalalgia (2013) 1.50
Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain (2012) 1.40
Spinal Cord Injury and Migraine Headache: A Population-Based Study. PLoS One (2015) 1.40
Acute headache diagnosis in pregnant women: a hospital-based study. Neurology (2015) 1.37
Alcohol and migraine: trigger factor, consumption, mechanisms. A review. J Headache Pain (2008) 1.16
Association between migraine, lifestyle and socioeconomic factors: a population-based cross-sectional study. J Headache Pain (2011) 1.14
Effects of stratification in the analysis of affected-sib-pair data: benefits and costs. Am J Hum Genet (2000) 1.11
Meta-analysis of genome-wide association for migraine in six population-based European cohorts. Eur J Hum Genet (2011) 1.04
Modulation of CGRP-induced light aversion in wild-type mice by a 5-HT(1B/D) agonist. J Neurosci (2012) 0.98
Multisensory integration in migraine. Curr Opin Neurol (2013) 0.94
Frovatriptan: a review of pharmacology, pharmacokinetics and clinical potential in the treatment of menstrual migraine. Ther Clin Risk Manag (2006) 0.93
Low heat pain thresholds in migraineurs between attacks. Cephalalgia (2014) 0.93
Co-occurrence of major depression or suicide attempt with migraine with aura and risk for unprovoked seizure. Epilepsy Res (2007) 0.91
Self-reported menstrual migraine in the general population. J Headache Pain (2010) 0.89
Acute migraine: Current treatment and emerging therapies. Ther Clin Risk Manag (2007) 0.87
Investigation of gamma-aminobutyric acid (GABA) A receptors genes and migraine susceptibility. BMC Med Genet (2008) 0.85
[Alimentary trigger factors that provoke migraine and tension-type headache]. Schmerz (2006) 0.84
Correlations between brain cortical thickness and cutaneous pain thresholds are atypical in adults with migraine. PLoS One (2014) 0.83
Is migraine a genetic illness? The various forms of migraine share a common genetic cause. Neurol Sci (2008) 0.83
Heritability and genome-wide linkage analysis of migraine in the genetic isolate of Norfolk Island. Gene (2011) 0.83
Are menstrual and nonmenstrual migraine attacks different? Curr Pain Headache Rep (2011) 0.80
Hereditary patterns of Belgrade university female students with migraine and nonmigraine primary headache. J Neurol (2004) 0.80
[Non-alimentary trigger factors of migraine and tension-type headache]. Schmerz (2006) 0.80
Functional imaging and migraine: new connections? Curr Opin Neurol (2015) 0.79
Genetics of menstrual migraine: the epidemiological evidence. Curr Pain Headache Rep (2010) 0.79
A review of frovatriptan for the treatment of menstrual migraine. Int J Womens Health (2014) 0.79
Contraceptive-induced amenorrhoea leads to reduced migraine frequency in women with menstrual migraine without aura. J Headache Pain (2014) 0.78
Photophobia and abnormally sustained pupil responses in a mouse model of bradyopsia. Invest Ophthalmol Vis Sci (2014) 0.78
Clinical review of headache in pregnancy. Neurol Sci (2010) 0.78
Is migraine a risk factor for pediatric stroke? Cephalalgia (2015) 0.78
Trigger factors in primary headaches subtypes: a cross-sectional study from a tertiary centre in Greece. BMC Res Notes (2015) 0.77
Sensitivity and specificity of the new international diagnostic criteria for migraine with aura. J Neurol Neurosurg Psychiatry (2005) 0.77
Temporal lobe cortical thickness correlations differentiate the migraine brain from the healthy brain. PLoS One (2015) 0.76
Arctic environment triggers migraine attacks. Can Fam Physician (2010) 0.76
Dietary patterns according to headache and migraine status: a cross-sectional study. Cephalalgia (2014) 0.76
Genotype-phenotype correlation in migraine without aura focusing on the rs1835740 variant on 8q22.1. J Headache Pain (2011) 0.75
MO and MA: distinct clinical entities? Cephalalgia (1996) 0.75
Structural alterations of the brainstem in migraine. Neuroimage Clin (2016) 0.75
Alcohol-induced headaches: Evidence for a central mechanism? J Neurosci Rural Pract (2016) 0.75
Prevalence of Irritable Bowel Syndrome (IBS), Migraine and Co-Existing IBS-Migraine in Medical Students. J Clin Diagn Res (2016) 0.75
Photophobia in neurologic disorders. Transl Neurodegener (2017) 0.75
Ion channelopathies and migraine pathogenesis. Mol Genet Genomics (2017) 0.75
The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 9.40
New appendix criteria open for a broader concept of chronic migraine. Cephalalgia (2006) 5.97
Understanding the biologic basis of migraine. N Engl J Med (1994) 5.25
Epidemiology of headache in a general population--a prevalence study. J Clin Epidemiol (1991) 4.78
Autoregulation of brain circulation in severe arterial hypertension. Br Med J (1973) 4.11
The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache. Cephalalgia (2005) 2.86
A yeast and a human CCAAT-binding protein have heterologous subunits that are functionally interchangeable. Cell (1988) 2.84
Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutat (1994) 2.44
CGRP may play a causative role in migraine. Cephalalgia (2002) 2.40
Questionnaire versus clinical interview in the diagnosis of headache. Headache (1991) 2.36
Migraine prevalence. A review of population-based studies. Neurology (1994) 2.34
Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia (1992) 2.33
Delayed hyperemia following hypoperfusion in classic migraine. Single photon emission computed tomographic demonstration. Arch Neurol (1988) 2.30
Regional cerebral blood flow in man determined by the initial slope of the clearance of intra-arterially injected 133Xe. Stroke (1974) 2.26
Impact of headache on sickness absence and utilisation of medical services: a Danish population study. J Epidemiol Community Health (1992) 2.12
Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan. Lancet (1991) 2.11
Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee. Neurology (2000) 2.10
Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol (1981) 2.03
Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia (2006) 2.01
Phosphorylation regulates in vivo interaction and molecular targeting of serine/arginine-rich pre-mRNA splicing factors. J Cell Biol (1999) 2.00
Symptomatic and nonsymptomatic headaches in a general population. Neurology (1992) 1.99
The genetic spectrum of a population-based sample of familial hemiplegic migraine. Brain (2006) 1.97
Prevalence and sex-ratio of the subtypes of migraine. Int J Epidemiol (1995) 1.96
Increased familial risk and evidence of genetic factor in migraine. BMJ (1995) 1.96
A nosographic analysis of the migraine aura in a general population. Brain (1996) 1.91
Cerebral blood flow velocities are reduced during attacks of unilateral migraine without aura. Cephalalgia (1995) 1.82
Premonitory symptoms in migraine: an electronic diary study. Neurology (2003) 1.81
Improved description of the migraine aura by a diagnostic aura diary. Cephalalgia (1994) 1.68
Dilation by CGRP of middle meningeal artery and reversal by sumatriptan in normal volunteers. Neurology (2010) 1.66
Pressure-controlled palpation: a new technique which increases the reliability of manual palpation. Cephalalgia (1995) 1.64
Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs. Cephalalgia (1996) 1.62
Double-blind, randomized, placebo-controlled study of oral, high-dose methylprednisolone in attacks of MS. Neurology (1998) 1.62
Monitoring tissue oxygen availability with near infrared spectroscopy (NIRS) in health and disease. Scand J Med Sci Sports (2001) 1.60
Subcutaneous sumatriptan during the migraine aura. Sumatriptan Aura Study Group. Neurology (1994) 1.59
Evidence of qualitatively altered nociception in patients with fibromyalgia. Arthritis Rheum (1997) 1.58
Presentation of a new instrument: the diagnostic headache diary. Cephalalgia (1992) 1.57
Muscle palpation with controlled finger pressure: new equipment for the study of tender myofascial tissues. Pain (1994) 1.54
Interrelations between migraine and tension-type headache in the general population. Arch Neurol (1992) 1.53
Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial. Lancet (1999) 1.52
Increased risk of migraine with typical aura in probands with familial hemiplegic migraine and their relatives. Eur J Neurol (2003) 1.49
Crime in Huntington's disease: a study of registered offences among patients, relatives, and controls. J Neurol Neurosurg Psychiatry (1998) 1.49
Diagnosis and management of migraine. BMJ (1996) 1.47
Botulinum toxin in headache treatment: the end of the road? Cephalalgia (2006) 1.46
The effect of intracarotid epinephrine, norepinephrine, and angiotensin on the regional cerebral blood flow in man. Neurology (1972) 1.46
Muscular disorders in tension-type headache. Cephalalgia (1996) 1.46
Calcitonin gene-related peptide (CGRP) levels during glyceryl trinitrate (GTN)-induced headache in healthy volunteers. Cephalalgia (2010) 1.45
Nitroglycerin-induced headache is not dependent on histamine release: support for a direct nociceptive action of nitric oxide. Cephalalgia (1994) 1.44
Possible mechanisms of action of nitric oxide synthase inhibitors in chronic tension-type headache. Brain (1999) 1.43
The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers. Cephalalgia (2005) 1.39
The International classification of headache disorders, 2nd edn (ICDH-II). J Neurol Neurosurg Psychiatry (2004) 1.39
Exteroceptive suppression of temporal muscle activity is normal in chronic tension-type headache and not related to actual headache state. Cephalalgia (1996) 1.39
Evaluation of pericranial myofascial nociception by pressure algometry. Reproducibility and factors of variation. Cephalalgia (1992) 1.39
Myofibre damage in human skeletal muscle: effects of electrical stimulation versus voluntary contraction. J Physiol (2007) 1.38
[Decreased pain threshold and tolerance in patients with chronic tension headache]. Ugeskr Laeger (1997) 1.38
Pressure-sensitive devices. Pain (1995) 1.38
[Are psychiatric diseases brain diseases?]. Ugeskr Laeger (1999) 1.38
[Sumatriptan (Imigran) to patients with hemiplegic migraine?]. Ugeskr Laeger (1992) 1.38
Resource allocation to brain research in Europe (RABRE). Eur J Neurosci (2006) 1.34
A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria. Brain (2002) 1.34
Evidence of a genetic factor in migraine with aura: a population-based Danish twin study. Ann Neurol (1999) 1.33
Significantly lower incidence of cancer among patients with Huntington disease: An apoptotic effect of an expanded polyglutamine tract? Cancer (1999) 1.31
Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics. Pain (1989) 1.31
A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry (1996) 1.27
Incidence of primary headache: a Danish epidemiologic follow-up study. Am J Epidemiol (2005) 1.27
Quantitative evaluation of normal and pathologic cerebral blood flow regulation to perfusion pressure. Changes in man. Arch Neurol (1973) 1.25
Sporadic hemiplegic migraine. Cephalalgia (2004) 1.25
Causes of death in patients with Huntington's disease and in unaffected first degree relatives. J Med Genet (1992) 1.24
Assessment of demyelination, edema, and gliosis by in vivo determination of T1 and T2 in the brain of patients with acute attack of multiple sclerosis. Magn Reson Med (1989) 1.23
Regional cerebral blood flow during migraine attacks by Xenon-133 inhalation and emission tomography. Brain (1984) 1.20
The effects of PaCO2 on regional cerebral blood flow and internal carotid arterial pressure during carotid clamping. Anesthesiology (1971) 1.18
The relative role of genetic and environmental factors in migraine without aura. Neurology (1999) 1.17
Inheritance of migraine investigated by complex segregation analysis. Hum Genet (1995) 1.16
Efficacy of multidisciplinary treatment in a tertiary referral headache centre. Cephalalgia (2005) 1.16
Screening for migraine in the general population: validation of a simple questionnaire. Cephalalgia (1998) 1.16
Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura. Cephalalgia (1999) 1.15
Leao's spreading depression in the hippocampus explains transient global amnesia. A hypothesis. Acta Neurol Scand (1986) 1.15
Trinucleotide repeat elongation in the Huntingtin gene in Huntington disease patients from 71 Danish families. Hum Mol Genet (1993) 1.15
The impact of migraine: Epidemiology, risk factors, and co-morbidities. Neurology (2001) 1.14
Pressure-pain threshold in human temporal region. Evaluation of a new pressure algometer. Pain (1986) 1.13
Contralateral focal increase of cerebral blood flow in man during arm work. Brain (1971) 1.13
Analgesic headache. BMJ (1995) 1.13
The Copenhagen Acute Headache Clinic: organization, patient material and treatment results. Headache (1979) 1.12
Mortality, pathological findings and causes of death in the de Lange syndrome. Acta Paediatr Scand (1985) 1.11
Pericranial tenderness in tension headache. A blind, controlled study. Cephalalgia (1987) 1.11
Migraine without aura and migraine with aura are inherited disorders. Cephalalgia (1996) 1.11
A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks. Eur J Neurol (1994) 1.10
Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks. Pain (2000) 1.09
Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Cephalalgia (2008) 1.09
Secular changes in health care utilization and work absence for migraine and tension-type headache: a population based study. Eur J Epidemiol (2005) 1.09
Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study. Neurology (1994) 1.09
Some clinical features of the acute migraine attack. An analysis of 750 patients. Headache (1978) 1.09
Classification of primary headaches. Neurology (2004) 1.08